LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,623 | -16.4% | 12,499 | 0.0% | 0.01% | -7.1% |
| Q2 2023 | $17,498 | -6.7% | 12,499 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $18,748 | +29.3% | 12,499 | 0.0% | 0.02% | +33.3% |
| Q4 2022 | $14,498 | +3.6% | 12,499 | 0.0% | 0.01% | -7.7% |
| Q3 2022 | $14,000 | -30.0% | 12,499 | 0.0% | 0.01% | -27.8% |
| Q2 2022 | $20,000 | +5.3% | 12,499 | 0.0% | 0.02% | +28.6% |
| Q1 2022 | $19,000 | -38.7% | 12,499 | 0.0% | 0.01% | -41.7% |
| Q4 2021 | $31,000 | 0.0% | 12,499 | 0.0% | 0.02% | -11.1% |
| Q3 2021 | $31,000 | -11.4% | 12,499 | 0.0% | 0.03% | -10.0% |
| Q2 2021 | $35,000 | +20.7% | 12,499 | 0.0% | 0.03% | +15.4% |
| Q1 2021 | $29,000 | – | 12,499 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |